GlassScriptPhysician profile
Anthony P Dota
NPI 1568653384
$17,570.92
in general payments reported to CMS, 2019-2025
46 companies · $3,434 in 2025
The $3,434 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,505 · 2020: $1,304 · 2021: $1,523 · 2022: $2,931 · 2023: $3,058 · 2024: $2,815 · 2025: $3,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,307.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,406.14 | 2021-2025 | Endurant Iis, Corevalve Evolut R, Valiant Captivia |
| Abbott Laboratories | $2,032.94 | 2019-2025 | Navitor, Jot Dx, Aveir |
| Shockwave Medical, INC | $1,753.02 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $1,578.20 | 2019-2023 | Indigo System |
| Abiomed | $1,290.35 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $1,268.08 | 2019-2025 | |
| Edwards Lifesciences Corporation | $1,116.50 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque |
| Amgen INC. | $669.72 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $587.94 | 2019-2025 | Camzyos, Eliquis |
| Philips North America LLC | $409.25 | 2019-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Boston Scientific Corporation | $409.20 | 2019-2025 | Watchman Flx |
| Pfizer INC. | $387.49 | 2021-2025 | |
| Cvrx, INC. | $326.99 | 2024-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $323.14 | 2021-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $262.35 | 2022-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $259.38 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $234.94 | 2020-2024 | Definity |
| Janssen Pharmaceuticals, INC | $209.54 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $205.16 | 2021-2024 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Novo Nordisk INC | $202.71 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $196.93 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.41 | 2021-2025 | Lifevest |
| Heartflow, INC. | $156.18 | 2022-2025 | Ffrct |
| Alnylam Pharmaceuticals INC. | $120.48 | 2025 | Amvuttra |
| Siemens Medical Solutions USA, INC. | $110.06 | 2019 | |
| Itamar Medical INC | $107.93 | 2023-2025 | Watchpatone |
| Irhythm Technologies, INC. | $89.79 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Bridgebio Pharma, INC. | $78.16 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $65.33 | 2019-2024 | Andexxa, Farxiga |
| Acist Medical Systems, INC. | $63.68 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $55.41 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $46.03 | 2022-2023 | Arcalyst |
| Cardiovascular Systems INC. | $44.95 | 2019-2020 | |
| Atricure, INC. | $44.55 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $34.97 | 2019-2022 | |
| Lilly USA, LLC | $33.51 | 2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $31.49 | 2021-2025 | |
| Ge Healthcare | $27.06 | 2024 | |
| Teleflex LLC | $26.92 | 2023 | Manta |
| Inari Medical, INC. | $25.76 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.10 | 2021 | |
| Amarin Pharma, INC. | $23.30 | 2021 | |
| Esperion Therapeutics, INC. | $21.10 | 2025 | Nexletol |
| Vifor Pharma, INC. | $17.91 | 2021 | |
| Astellas Pharma US INC | $16.03 | 2019 | |
| Chiesi USA, INC. | $15.84 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Dota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.